AMANDA BRATTON: Open Payments
NPI 1093127607 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,142 in 108 payments from 19 companies in 2025. Trend: 2023 $46 · 2024 $121 · 2025 $2,142
Food & beverage: $2,091Education: $51
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $422 |
| GlaxoSmithKline, LLC. | 10 | $254 |
| Verona Pharma, Inc. | 17 | $218 |
| Axsome Therapeutics, Inc. | 9 | $181 |
| Viatris Specialty LLC | 15 | $159 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| Insmed, Inc. | 6 | $103 |
| JAZZ PHARMACEUTICALS INC. | 4 | $98 |
| Grifols USA, LLC | 5 | $96 |
| Amgen Inc. | 4 | $91 |
Products named: Ohtuvayre, Sunosi, DUPIXENT, TEZSPIRE, YUPELRI, FASENRA, TRELEGY ELLIPTA, XYWAV.
Industry payments across IN — which companies pay providers there.
